Safex Chemicals Acquires Briar Chemicals from AURELIUS
October 10, 2022
Safex Chemicals India Limited has acquired Briar Chemicals Limited, a leading UK agrochemical CDMO based in Norwich, from AURELIUS Equity Opportunities. The transaction, signed and closed on October 10, 2022, is valued at approximately EUR 83 million; Briar operates a large 115-acre manufacturing site with around 250 employees.
- Buyers
- Safex Chemicals India Limited
- Targets
- Briar Chemicals Limited
- Sellers
- AURELIUS Equity Opportunities SE & Co. KGaA
- Industry
- Agriculture
- Location
- Norfolk, United Kingdom
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Ascensus Specialties Acquires Wychem Limited from AURELIUS Equity Opportunities
December 13, 2021
Manufacturing
Ascensus Specialties LLC has acquired Wychem Limited, a UK-based independent fine chemical manufacturer, from AURELIUS Equity Opportunities. The acquisition expands Ascensus' European manufacturing footprint and adds Wychem's capabilities in aromatic compounds, halogenation and multi-step intermediates for pharmaceutical APIs; financial terms were not disclosed by Ascensus, while AURELIUS reported a 10.6x money-over-money multiple on the sale.
-
Saur Group Acquires Aqua-Chem
July 12, 2022
Environmental Services
France-based Saur Group, an EQT‑backed environmental services company, has acquired Knoxville, Tennessee‑headquartered Aqua‑Chem. Aqua‑Chem will become the North American platform and the water purification global center of excellence for Nijhuis Saur Industries (NSI), expanding Saur's process water and purification capabilities across pharmaceuticals, beverage, energy and military end markets.
-
Pharmaron Acquires 82.54% of Biortus Biosciences
October 28, 2025
Healthcare Services
Pharmaron Beijing Co., Limited has entered into a definitive Share Purchase Agreement to acquire 82.54% of Biortus Biosciences Co., Ltd. and its affiliates. The transaction is expected to close after satisfaction of customary closing conditions and is intended to strengthen Pharmaron’s structure-based drug discovery and protein science capabilities.
-
AURELIUS Acquires McKesson UK (owner of LloydsPharmacy, AAH Pharmaceuticals)
November 1, 2021
Healthcare Services
AURELIUS has completed the acquisition of McKesson UK, a corporate carve‑out from McKesson Corporation that includes LloydsPharmacy, AAH Pharmaceuticals and John Bell & Croyden. The transaction is led by AURELIUS’ co‑investment structure (AURELIUS European Opportunities Fund IV 70% / AURELIUS Equity Opportunities SE & Co. KGaA 30%) and positions the firm to grow McKesson UK’s retail, digital, homecare and wholesale businesses.
-
AURELIUS Acquires McKesson UK (including LloydsPharmacy and AAH Pharmaceuticals)
November 11, 2021
Healthcare Services
AURELIUS (AURELIUS Equity Opportunities / Aurelius Group) agreed to acquire McKesson’s UK businesses in November 2021, a transaction that included LloydsPharmacy and AAH Pharmaceuticals and was reported at roughly £477 million. The deal, a carve‑out from McKesson Corporation, was described by AURELIUS as the largest transaction in the company’s history and expands its healthcare services footprint in the United Kingdom.
-
Azelis Acquires Whitfield Chemical Group (WhitChem) in the UK
March 16, 2022
Industrial Services
Azelis has acquired 100% of the shares of Whitfield Chemical Group Limited, the parent company of WhitChem, strengthening Azelis' industrial chemicals footprint in the UK and EMEA. WhitChem, a UK-based distributor focused on CASE and R&PA, employs about 30 staff and will keep its management in place to support integration and growth.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.